Investors Sizing Up Possible Direction for S&P 500 in 2025
2025 has begun the way 2024 ended. With investors doing their best to determine what direction stock prices will go during the next year.
As the year gets underway, expectations of how the U.S. Federal Reserve will be setting stock prices continues to be the dominant factor affecting how far forward in time investors are focusing their attention. At this writing, the CME Group’s FedWatch Tool continues to anticipate just one rate cut in all of 2025 in its full-year forecast. The only projected rate cut currently on the radar is a 0.25% reduction in the Federal Funds Rate on 7 May (2025-Q2).
That expectation puts the second quarter of 2025 directly in the long range scopes of investors. The final update to the alternative futures chart for 2024-Q4 confirms the level of stock prices is tracking within the lower end of the expected range associated with investors focusing their forward-looking attention on this distant future quarter.
As the first trading days of 2025 have passed, the S&P 500 (Index: SPX) closed out the two past holiday-shortened trading weeks at 5,942.47, up just 11.60 points or 0.2% from the index’ level two weeks earlier.
Which is to say the random onset of new information during the past two weeks has done little to affect investor expectations for the future of stock prices. Here are market moving headlines we noted during these two weeks.
- Monday, 23 December 2024
-
- Signs and portents for the U.S. economy:
- US new home sales rebound in November after hurricane drag
- Shrinking US bar tabs signal little festive cheer for liquor makers
- Oil prices ease on surplus concerns, dollar strength
- Signs of growth, such as it is, developing in China:
- Bigger trouble developing in Eurozone, ECB minions thinking they could change gears and cut interest rates further:
- Europe’s embattled auto sector plans plant closures and layoffs
- Europe’s energy taxes are worsening industry woes, power CEO says
- Lagarde says ECB very close to reaching its inflation goal, FT reports
- Dow, S&P, and Nasdaq trade mixed on the holiday-shortened trading week
- Tuesday, 24 December 2024
-
- Signs and portents for the U.S. economy:
- Bigger stimulus developing in China:
- BOJ minions say next year is the one they’ll finally hit their inflation target for Japan:
- Wall Street ends higher as Santa rally begins
- Thursday, 26 December 2024
-
- Signs and portents for the U.S. economy:
- Oil prices ease as markets weigh China stimulus hopes
- New US jobless claims slip, but people are remaining unemployed for longer
- Bigger stimulus, bailouts developing in China:
- Exclusive: China plans record $411 billion special treasury bond issuance next year
- China Stimulus Pledges All Pledge to Recapitalize State Banks
- Wall Street ends topsy-turvy session mixed, putting Santa rally under pressure
- Friday, 27 December 2024
-
- Signs and portents for the U.S. economy:
- U.S. Inflation Has Turned ‘Sticky’, Reducing Odds For Rate Cuts
- Intel leads 2024 tech layoffs, but sector lays off 43% less year over year
- US homelessness rose by record 18% in latest annual data
- BOJ minions quantify how much they think their future rate hikes will hurt Japan’s businesses:
- BOJ produces estimates on how future rate hikes affect earnings
- Inflation in Japan’s capital accelerates, keeps rate hike prospects intact
- Yen gains as some BOJ policymakers see rate hike soon
- Wall St finishes down after sell-off at end of strong holiday-shortened week
- Monday, 30 December 2024
-
- Signs and portents for the U.S. economy:
- Oil rises on diesel demand boost in sparse holiday trade
- US credit card defaults jump to highest level since 2010
- Mixed economic signs developing in China:
- Chinese youth flock to civil service, but slow economy puts ‘iron rice bowl’ jobs at risk
- China’s Dec manufacturing activity seen expanding for third month: Reuters poll
- Less bad trouble developing in Japan:
- Bigger trouble developing in South Korea:
- Nasdaq, S&P, and Dow sink alongside Treasury yields as 2025 approaches
- Tuesday, 31 December 2024
-
- Signs and portents for the U.S. economy:
- US oil executives expect faster permitting under Trump, says Dallas Fed
- US oil production rose to record high in October, EIA data shows
- Oil prices post 3% annual decline, slipping for second year in a row
- Bigger trouble, stimulus developing in China:
- China’s Economy Is Burdened by Years of Excess. Here’s How Bad It Really Is
- China’s Xi expects 2024 GDP growth of around 5%, state media says
- China’s Xi pledges more proactive economic policies in 2025
- Wall Street ends lower, capping a banner year
- Thursday, 2 January 2025
-
- Signs and portents for the U.S. economy:
- Oil prices settle up on China optimism as investors return from holiday
- US weekly jobless claims hit eight-month low as labor market remains resilient
- US 30-year fixed-rate mortgage flirts with 7%
- Bigger trouble, stimulus developing in China:
- Wall Street reverses course, erases nearly 1% gain in volatile first trading day of 2025
- Friday, 3 January 2025
-
- Signs and portents for the U.S. economy:
- US manufacturing PMI rises to nine-month high in December
- US new car sales rose to five-year high in 2024, helped by hybrids
- Fed minions say the year ahead looks great, although they’ll keep interest rates higher for longer because of persistent Bidenflation:
- Fed’s Barkin: Year-ahead outlook positive, with upside risk
- Fed policy may need to stay restrictive for longer due to inflation risk, Barkin says
- Bigger trouble, stimulus developing in China:
- Trouble in China’s shopping paradise as Hainan duty-free spending tumbles
- China will sharply increase funding from treasury bonds to spur growth in 2025
- China gives government workers first big pay bump in a decade to boost economy
- Wall Street shakes off recent weakness, snaps longest losing streak since April
The Atlanta Fed’s GDPNow tool‘s projection of the real GDP growth rate for the current quarter of 2024-Q4 declined to +2.4% from the pre-Christmas holiday week’s +3.1% annualized growth estimate.
In our next edition, we’ll roll the alternative futures chart forward to provide a first look at the potential levels of the S&P 500 through 2025-Q1. On another programming note, this is the first of two editions of the S&P 500 chaos series that we anticipate will span a two week long period in 2025. The second will come during the middle of the summer doldrums and will cover the last week of July and first week of August 2025.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull and bear discussing what direction to go in 2025″.
Source: https://politicalcalculations.blogspot.com/2025/01/investors-sizing-up-possible-direction.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.